PERIPHERAL ARTERIAL DISEASE (PAD)
Clinical trials for PERIPHERAL ARTERIAL DISEASE (PAD) explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL ARTERIAL DISEASE (PAD) trials appear
Sign up with your email to follow new studies for PERIPHERAL ARTERIAL DISEASE (PAD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI contrast agent may improve artery blockage detection
Diagnosis CompletedThis study tested two MRI methods for finding narrowed or blocked arteries in the pelvis and legs of people with peripheral arterial disease (PAD). One method uses a special contrast agent called ferumoxytol to make blood vessels stand out, while the other relies on natural blood…
Matched conditions: PERIPHERAL ARTERIAL DISEASE (PAD)
Phase: PHASE2 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Diagnosis
Last updated May 17, 2026 07:35 UTC
-
Researchers check blood thinner safety in japanese PAD patients after surgery
Knowledge-focused CompletedThis study looked at the safety of the blood thinner rivaroxaban in 1500 Japanese people with peripheral artery disease (PAD) who had surgery to improve blood flow to their legs. Researchers used existing health records to track bleeding events and heart-related deaths. No new tr…
Matched conditions: PERIPHERAL ARTERIAL DISEASE (PAD)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 17, 2026 07:34 UTC